Suppr超能文献

IL-13 对气道平滑肌细胞中 Ca2+ 释放和储存操纵型 Ca2+ 内流的促进作用。

Promoting effects of IL-13 on Ca2+ release and store-operated Ca2+ entry in airway smooth muscle cells.

机构信息

Department of Respiratory Medicine, Zhongnan Hospital, Wuhan University, Wuhan 430071, PR China.

出版信息

Pulm Pharmacol Ther. 2010 Jun;23(3):182-9. doi: 10.1016/j.pupt.2009.12.005. Epub 2010 Jan 4.

Abstract

Th2 cytokine interleukin (IL)-13 plays a central role in the pathogenesis of allergic asthma. IL-13 exhibits a direct effect on airway smooth muscle cells (ASMCs) to cause airway hyperresponsiveness. IL-13 has been demonstrated to regulate Ca(2+) signaling in ASMCs, but the underlying mechanisms are not fully understood. Store-operated Ca(2+) entry (SOCE) plays an important role in regulating Ca(2+) signaling and cellular responses of ASMCs, whether IL-13 affects SOCE in ASMCs has not been reported. In this study, by using confocal Ca(2+) fluorescence imaging, we found that IL-13 (10 ng/ml) treatment increased basal intracellular Ca(2+) (Ca(2+)) level, Ca(2+) release and SOCE induced by SERCA inhibitor thapsigargin in rat bronchial smooth muscle cells. The glucocorticoid dexamethasone and the short-acting beta2 adrenergic agonist (beta2 agonist) salbutamol suppressed IL-13-augumented basal Ca(2+), Ca(2+) release and SOCE, whereas the long-acting beta2 agonist salmeterol had no effect on altered Ca(2+) signaling in IL-13-treated ASMCs. Membrane-permeable cAMP analog dibutyryl-cAMP (db-cAMP) similarly decreased Ca(2+) release and SOCE induced by thapsigargin in IL-13-treated ASMCs, confirmed a role of cAMP/PKA signaling pathway in the regulation of SOCE. IL-13 promoted the proliferation of ASMCs stimulated by serum; this effect was inhibited by nonspecific Ca(2+) channel blockers SKF-96365 and NiCl(2), by salmeterol, but not by salbutamol and dexamethasone. IL-13 treatment did not change the expression of SOC channel-associated molecules STIM1, Orai1 and TRPC1 at mRNA level. Our findings identified a promoting effect of IL-13 on Ca(2+) release and SOCE in ASMCs, which partially contributes to its effect on the proliferation of ASMCs; the differences of glucocorticoids and beta2 agonists in inhibiting Ca(2+) signal and proliferation potentiated by IL-13 suggest that these therapies of asthma may have distinct effect on the relief of airway contraction and remodeling in bronchial asthma.

摘要

Th2 细胞因子白细胞介素 (IL)-13 在过敏性哮喘的发病机制中起核心作用。IL-13 对气道平滑肌细胞 (ASMCs) 有直接作用,导致气道高反应性。IL-13 已被证明可调节 ASMCs 中的 Ca(2+) 信号,但具体机制尚不完全清楚。储存操纵的 Ca(2+) 内流 (SOCE) 在调节 ASMCs 的 Ca(2+) 信号和细胞反应中起重要作用,但是否 IL-13 影响 ASMCs 中的 SOCE 尚未报道。在这项研究中,通过共聚焦 Ca(2+) 荧光成像,我们发现白细胞介素 13(10ng/ml)处理可增加大鼠支气管平滑肌细胞的基础细胞内 Ca(2+) (Ca(2+)) 水平、钙释放和肌浆网 Ca2+-ATP 酶抑制剂 thapsigargin 诱导的 SOCE。糖皮质激素地塞米松和短效 β2 激动剂(β2 激动剂)沙丁胺醇抑制白细胞介素 13 增强的基础 Ca(2+)、钙释放和 SOCE,而长效 β2 激动剂沙美特罗对白细胞介素 13 处理的 ASMCs 中改变的 Ca(2+) 信号没有影响。膜可渗透的 cAMP 类似物二丁酰环磷酸腺苷 (db-cAMP) 也可类似地降低 thapsigargin 诱导的白细胞介素 13 处理的 ASMCs 中的钙释放和 SOCE,证实 cAMP/PKA 信号通路在调节 SOCE 中的作用。白细胞介素 13 促进血清刺激的 ASMC 增殖;该作用被非特异性钙通道阻滞剂 SKF-96365 和 NiCl(2)、沙美特罗抑制,但沙丁胺醇和地塞米松不抑制。白细胞介素 13 处理未改变 SOC 通道相关分子 STIM1、Orai1 和 TRPC1 在 mRNA 水平的表达。我们的发现确定了白细胞介素 13 对 ASMCs 中 Ca(2+) 释放和 SOCE 的促进作用,这部分有助于其对 ASMCs 增殖的作用;糖皮质激素和 β2 激动剂在抑制 Ca(2+) 信号和白细胞介素 13 增强的增殖方面的差异表明,这些哮喘治疗方法可能对支气管哮喘中气道收缩和重塑的缓解具有不同的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验